Industry News

More Industry News

GSK is evaluating acquisitions in India, CEO says

3/10/2010

GlaxoSmithKline is considering deals to buy or work with Indian drugmakers, according to this article. In a Q-and-A, CEO Andrew Witty said the company will reduce the price of its drugs in India to extend its reach with low-income consumers. The drugmaker will also collaborate with local companies to cut production costs, Witty said. GSK is interested in acquisitions to increase its business in India, but only at the right price, he said.

Read More

Regulatory News

FDA unit launches workshops to encourage orphan-drug applications

3/10/2010

The FDA's Office of Orphan Products Development is hosting workshops to encourage research into treatments for rare diseases among drug and biotech companies, academic institutes as well as patient advocates. The first seminar was held last month and resulted in 14 submissions for orphan-drug status out of 29 potential sponsors, but Timothy Coté, director of the division, said he hopes to gather more applications during the second workshop in August.

Read More

Online Newsletters

As a Registered INTERPHEX365 Subscriber, you will be receiving monthly INTERPHEX365 Reporter newsletters electronically. This online publication, published in cooperation with SmartBrief, will summarize the highlights of each month with unique commentary on the industry news.

Issues of past monthly newsletters will be stored here in an Archive.

If you haven't already done so, we encourage you to Register to take full advantage of site functionality, including industry news and participation in the Business Discussion Forums.